Select Medical Holdings Stock Cash And Equivalents
| SEM Stock | USD 39.07 0.98 2.57% |
Select Medical Holdings fundamentals help investors to digest information that contributes to Select Medical's financial success or failures. It also enables traders to predict the movement of Select Stock. The fundamental analysis module provides a way to measure Select Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Select Medical stock.
| Last Reported | Projected for Next Year | ||
| Cash And Equivalents | 112.6 M | 107 M |
Select | Cash And Equivalents |
Select Medical Holdings Company Cash And Equivalents Analysis
Select Medical's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Select Medical Cash And Equivalents | 97.91 M |
Most of Select Medical's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Select Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Select Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for Select Medical is extremely important. It helps to project a fair market value of Select Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Select Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Select Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Select Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Select Cash And Equivalents Historical Pattern
Today, most investors in Select Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Select Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash and equivalents growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Select Medical cash and equivalents as a starting point in their analysis.
Select Medical Cash And Equivalents |
| Timeline |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Select Medical Holdings has 97.91 M in Cash And Equivalents. This is 88.07% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 96.38% higher than that of the company.
Select Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Select Medical's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Select Medical could also be used in its relative valuation, which is a method of valuing Select Medical by comparing valuation metrics of similar companies.Select Medical is currently under evaluation in cash and equivalents category among its peers.
Select Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Select Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Select Medical's managers, analysts, and investors.Environmental | Governance | Social |
Select Fundamentals
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0484 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 9.29 B | ||||
| Shares Outstanding | 128.99 M | ||||
| Shares Owned By Insiders | 16.99 % | ||||
| Shares Owned By Institutions | 78.86 % | ||||
| Number Of Shares Shorted | 2.01 M | ||||
| Price To Earning | 13.33 X | ||||
| Price To Book | 2.57 X | ||||
| Price To Sales | 0.71 X | ||||
| Revenue | 6.66 B | ||||
| Gross Profit | 1.1 B | ||||
| EBITDA | 763.62 M | ||||
| Net Income | 299.73 M | ||||
| Cash And Equivalents | 97.91 M | ||||
| Cash Per Share | 1.35 X | ||||
| Total Debt | 4.96 B | ||||
| Debt To Equity | 3.68 % | ||||
| Current Ratio | 1.02 X | ||||
| Book Value Per Share | 14.79 X | ||||
| Cash Flow From Operations | 582.06 M | ||||
| Short Ratio | 4.35 X | ||||
| Earnings Per Share | 2.14 X | ||||
| Price To Earnings To Growth | 1.37 X | ||||
| Target Price | 45.4 | ||||
| Number Of Employees | 38.4 K | ||||
| Beta | 1.42 | ||||
| Market Capitalization | 4.91 B | ||||
| Total Asset | 7.69 B | ||||
| Retained Earnings | 751.86 M | ||||
| Working Capital | 9.18 M | ||||
| Current Asset | 749.15 M | ||||
| Current Liabilities | 729.28 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 7.69 B | ||||
| Last Dividend Paid | 0.5 |
About Select Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Select Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Select Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Select Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Select Medical Piotroski F Score and Select Medical Altman Z Score analysis. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.139 | Dividend Share 0.5 | Earnings Share 2.14 | Revenue Per Share 56.158 | Quarterly Revenue Growth 0.057 |
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.